example 184 [WO2014186035]   Click here for help

GtoPdb Ligand ID: 12668

Compound class: Synthetic organic
Comment: This compound is an inhibitor of indoleamine 2,3-dioxygenase 2 (ID02) that is intended to disrupt the tryptophan-kynurenine pathway for immunomodulatory potential [1]. IDO2 inhibitors are proposed to reverse kynurenine pathway-mediated immunosuppression that is associated with the tumour microenvironment.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 72
Molecular weight 338.31
XLogP 0.93
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=C(C=C(C(=C1)F)F)NC2=C(N)OC3=C2C=CN=C3C4=CC=NC=C4
Isomeric SMILES NC=1OC2=C(C3=CC=NC=C3)N=CC=C2C1NC4=CC=C(F)C(F)=C4
InChI InChI=1S/C18H12F2N4O/c19-13-2-1-11(9-14(13)20)24-16-12-5-8-23-15(17(12)25-18(16)21)10-3-6-22-7-4-10/h1-9,24H,21H2
InChI Key YZPRNUIZJURTKK-UHFFFAOYSA-N
References
1. Banerjee M, Middya S, Shrivastava R, Raina S, Surya A, Yadav DB, Yadav VK, Kapoor KK, Venkatesan A, Smith RA et al.. (2014)
Inhibitors of the kynurenine pathway.
Patent number: WO2014186035A1. Assignee: Curadev Pharma Private Ltd.. Priority date: 12/03/2014. Publication date: 20/11/2014.